
DexCom DXCM
$ 72.09
-1.82%
Annual report 2025
added 02-12-2026
Country |
|
IPO year |
2005 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
390 M |
Market Cap[1] |
$ 28.1 B |
EBITDA (LTM) |
$ 833 M |
P/E (LTM) |
51.27 |
P/S (LTM) |
6.82 |
EPS (LTM) |
1.43 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
$ 118.33 | -2.51 % | $ 36 B | NYSE,SPB | ||
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
- | - | $ 79.8 M | Nasdaq Capital Market | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Anixa Biosciences
ANIX
|
$ 2.93 | -1.68 % | $ 95.1 K | Nasdaq Capital Market | ||
|
VolitionRx Limited
VNRX
|
$ 0.2 | -3.8 % | $ 19.2 M | NYSE American | ||
|
Biodesix
BDSX
|
$ 16.26 | 6.03 % | $ 2.11 B | Nasdaq Global Market | ||
|
BioNano Genomics
BNGO
|
$ 1.15 | - | $ 1.46 M | Nasdaq Capital Market,SPB | ||
|
Burning Rock Biotech Limited
BNR
|
$ 26.0 | -0.95 % | $ 275 M | Nasdaq Global Market | ||
|
Bioventus
BVS
|
$ 8.55 | -2.62 % | $ 536 M | Nasdaq Global Select Market | ||
|
Brainsway Ltd.
BWAY
|
$ 23.46 | 1.38 % | $ 99.4 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 18.58 | -0.96 % | $ 990 M | Nasdaq Global Market,SPB | ||
|
Celcuity
CELC
|
$ 109.85 | -1.67 % | $ 4.33 B | Nasdaq Global Select Market | ||
|
Charles River Laboratories International
CRL
|
$ 176.99 | -0.84 % | $ 8.77 B | NYSE,SPB | ||
|
Castle Biosciences
CSTL
|
$ 28.6 | -3.28 % | $ 794 M | Nasdaq Global Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 212.21 | 0.14 % | $ 23.6 B | NYSE,SPB | ||
|
Danaher Corporation
DHR
|
$ 206.12 | -2.15 % | $ 147 B | NYSE,SPB | ||
|
DarioHealth Corp.
DRIO
|
$ 11.3 | -5.6 % | $ 321 M | Nasdaq Capital Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Exact Sciences Corporation
EXAS
|
$ 103.37 | -0.01 % | $ 19.5 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 14.52 | -5.28 % | $ 439 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 91.57 | -2.48 % | $ 11.5 B | Nasdaq Global Select Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 108.67 | 0.49 % | $ 8.96 B | Nasdaq Global Select Market,SPB | ||
|
IDEXX Laboratories
IDXX
|
$ 629.13 | -4.2 % | $ 50.6 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 131.17 | -2.45 % | $ 20.9 B | Nasdaq Global Select Market,SPB | ||
|
Interpace Biosciences
IDXG
|
$ 1.79 | 0.5 % | $ 7.85 M | Nasdaq Global Select Market | ||
|
IQVIA Holdings
IQV
|
$ 173.65 | -2.89 % | $ 29.9 B | NYSE,SPB | ||
|
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | ||
|
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | ||
|
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 285.48 | -1.26 % | $ 23.8 B | NYSE,SPB | ||
|
Lantheus Holdings
LNTH
|
$ 76.46 | 2.06 % | $ 5.16 B | Nasdaq Global Select Market,SPB | ||
|
Medpace Holdings
MEDP
|
$ 447.63 | -0.91 % | $ 12.9 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.